The derivation of AML-iPSCs, although successful for three AML patients with rearrangements in KMT2A/MLL (41, 59), has failed for AMLs with different mutations or lesions as well as KMT2A/MLL leukemic aberrations (41, 59). This evidence concerns the gene KMT2A and acute myeloid leukemia.